Abstract:The performance of small-diameter vascular grafts adapted to vascular replacement is commonly hin-dered by stenosis. To address this issue, a graft featuring rapid remodeling with degradation is war-ranted. In this work, a 1.8-mm-diameter graft was constructed by fabricating a decellularized human amniotic membrane (HAM) with polycaprolactone (PCL)/silk fibroin (SF) around it through electrospin-ning, namely, an HPS graft, and applied in a rat aortic grafting model for comparison to a decellularized porcine small intestinal submucosa (SIS)-integrated PCL/SF (SPS) graft and an autologous aorta. In vitro studies demonstrated that HAM provided a bioactive milieu for rapid endothelial cell proliferation and re-sisting fibroblast-induced collagen secretion. PCL/SF provides a biocompatible microenvironment for cel-lular infiltration with mechanical properties resembling those of the rat aorta. In vivo studies showed that the HPS graft induced functional endothelialization more rapidly, along with less intensive ECM deposi-tion than the SPS graft upon the histologically weaker inflammatory response and foreign body reaction 4 weeks after implantation, and maintained patency by progressively stabilizing the remodeling structure approximating the native counterparts over 24 weeks. The bioengineered graft expands the applicability of allogeneic matrices with degradable electrospun polymers for long-term in situ vascular applications.Statement of significanceAn orchestrated remodeling of the vascular graft, featuring rapid endothelialization and resisting extracel-lular matrix (ECM) deposition on the luminal surface, with a mechanically stable structure, is requisite for long-term vascular patency. Nevertheless, off-the-shelf grafts might not fulfil the criteria under abdom-inal aortic pressure. Herein, we fabricated a 1.8-mm-diameter vascular graft through the integration of a decellularized human amniotic membrane (HAM) with electrospun polycaprolactone (PCL)/silk fibroin (SF). In a rat aortic grafting model, the graft is capable of rapid endothelialization and resisting collagen deposition and provides a native-like mechanical structure for stabilizing the remodeling process towards that of the native aorta. This bioengineered graft has potential for small-diameter vascular regeneration, and provides advanced strategies to facilitate full-remodeling tissue applications.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

In Situ Blood Vessel Regeneration Using SP (substance P) and SDF (stromal Cell–Derived Factor)-1α Peptide Eluting Vascular Grafts

In Situ Blood Vessel Regeneration Using Neuropeptide Substance P-conjugated Small-Diameter Vascular Grafts.

Development of Small-Diameter Artificial Vascular Grafts Using Transgenic Silk Fibroin

Sustained Release of Stromal Cell-Derived Factor-1α from Injectable Hydrogels in Combination with Endothelial Progenitor Cells Effectively Promotes Neovascularization in Ischemic Diabetic Rats

Peptides-tethered Vascular Grafts Enable Blood Vessel Regeneration Via Endogenous Cell Recruitment and Neovascularization

The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration.

Anti-Sca-1 antibody-functionalized vascular grafts improve vascular regeneration via selective capture of endogenous vascular stem/progenitor cells

In Vitro Evaluation of Panax Notoginseng Rg1 Released from Collagen/chitosan-Gelatin Microsphere Scaffolds for Angiogenesis

A small-diameter vascular graft immobilized peptides for capturing endothelial colony-forming cells

Biofunctionalized Electrospun PCL-PIBMD/SF Vascular Grafts with PEG and Cell-Adhesive Peptides for Endothelialization

Immunomodulatory Porous Regenerative Scaffolds for Vascular Engineering

The effect of hypoxia-mimicking responses on improving the regeneration of artificial vascular grafts

The effect of Substance P/Heparin conjugated PLCL polymer coating of bioinert ePTFE vascular grafts on the recruitment of both ECs and SMCs for accelerated regeneration

Development of a Decellularized Human Amniotic Membrane-Based Electrospun Vascular Graft Capable of Rapid Remodeling for Small-Diameter Vascular Applications.

Nanofibrous Vascular Scaffold Prepared from Miscible Polymer Blend with Heparin/stromal Cell-Derived Factor-1 Alpha for Enhancing Anticoagulation and Endothelialization

Delivery of stromal cell-derived factor 1α for in situ tissue regeneration

Development of a Silk Fibroin-Small Intestinal Submucosa Small-Diameter Vascular Graft with Sequential VEGF and TGF-β1 Inhibitor Delivery for In Situ Tissue Engineering

Biomimetic tri-layered small-diameter vascular grafts with decellularized extracellular matrix promoting vascular regeneration and inhibiting thrombosis with the salidroside

MSC-derived Sevs Enhance Patency and Inhibit Calcification of Synthetic Vascular Grafts by Immunomodulation in a Rat Model of Hyperlipidemia

Development of a Silk Fibroin-Small Intestinal Submucosa Small-Diameter Vascular Graft with Sequential VEGF and TGF-<i></i>1 Inhibitor Delivery for In Situ Tissue Engineering

Engineered Vascular Graft Using Nanoscale Decellularized Arteries Modified with Controlled-Release Heparin and Vascular Endothelial Growth Factor